RE:Everyone is missing the point. Canadian MJ needs to riseWell articulated, but humbly disagree with some of your assertions. When buying a stock, imho, it's important to remember you're not buying the sector, but that particular stock only, based on its fundamentals. Of course if you're into ETF's, that's a whole different story.
Apha is completely different from the other cannastocks in Canada based on their positive ebitdas, high revenue and highest market share. Throw in CC Pharma and European/ South American expansion, and we should see rev increases quarter after quarter.
Agreed that the US market is expanding quickly (and so that's why I've invested in that too), but its federal legalizing issues will keep that market closed to only US citizens for some time...doesn't affect us at all. When they do become legal, they will have to either allow export/import both ways with Canada, or not at all for either. Still doesn't affect us.
At some point, and I believe soon, fundamentals will prevail, and Apha's price will separate itself
from the competition and start going north--and quickly--just like Facebook and Amazon have done from their competitiors.
And apha already has had a running start compared to US/Mexico, and is already entrenched itself here and internationally.
Not worried at all, and if you're right and a US co. buys us, I suspect it will be at a VERY high valuation.
Best to all longs,
hevin